Managed Healthcare Executive5h
FDA Grants Priority Review BLA for Spinal Muscular Atrophy Drug, Apitegromab
A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.
Bar and Bench18h
Delhi High Court allows Natco to make Roche's spinal muscular atrophy drug in public interest
The Delhi High Court on Monday dismissed an interim injunction application filed by Swiss pharmaceutical giant F Hoffmann-La ...
Savannah Tech waives app fees through end of March as part of state, national initiative
Savannah Technical College is waiving application fees for all programs through March 31.
Savannah Music Festival offers free student Explorer Pass and free School Spotlight Series
Review details on how Savannah public school students can access SMF's Explore Pass while the broader public can see the free ...
Arabian Gulf Business Insight on MSN22h
Profits of Muscat-listed companies surge over 50% in 2024
Net profits of publicly-listed companies on the Muscat Stock Exchange rose 53 percent to OMR1.3 billion ($3.4 billion) in 2024, compared to OMR877 million in 2023, according to a news report. Of ...
Moneylife16h
Natco Pharma Allowed to Make Roche's Spinal Muscular Atrophy Drug in Public Interest
The Delhi High Court on Monday dismissed an interim injunction application filed by Swiss pharmaceutical giant F Hoffmann-La ...